Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Furst

Showing results (291-300 of 477) with videos related to

Pageof 48
Sort By:
Annals of the Rheumatic Diseases|November 9, 2024
Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological studyJohannes Iuel Berg, Sabrina Mai Nielsen, Esben Malm, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 5, 2015
Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosisShervin Assassi, William R Swindell, Minghua Wu, et al.
The Journal of Rheumatology|January 30, 2010
Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritisHaoling H Weng, Veena K Ranganath, Dinesh Khanna, et al.
The Journal of Rheumatology|August 3, 2011
Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working GroupRieke Alten, Christof Pohl, Ernest H Choy, et al.
The Journal of Rheumatology|December 7, 2005
Outcome measures for acute and chronic goutH Ralph Schumacher, Lawrence N Edwards, Fernando Perez-Ruiz, et al.
Arthritis and Rheumatism|May 30, 2006
Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosisRichard A Nash, Peter A McSweeney, J Lee Nelson, et al.
The Journal of Rheumatology|August 18, 2009
Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group)Clifton O Bingham, Christoph Pohl, Thasia G Woodworth, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 15, 2014
Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung diseaseElizabeth R Volkmann, Rajeev Saggar, Dinesh Khanna, et al.
ACR Open Rheumatology|December 5, 2020
Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and IIElizabeth R Volkmann, Virginia Steen, Ning Li, et al.
Disability and Rehabilitation|March 20, 2020
Identifying barriers and facilitators to physical activity for people with scleroderma: a nominal group technique studySami Harb, Julie Cumin, Danielle B Rice, et al.
Pageof 48

Showing results (291-300 of 477) with videos related to

Sort By:
Pageof 48
Annals of the Rheumatic Diseases|November 9, 2024
Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological studyJohannes Iuel Berg, Sabrina Mai Nielsen, Esben Malm, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 5, 2015
Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosisShervin Assassi, William R Swindell, Minghua Wu, et al.
The Journal of Rheumatology|January 30, 2010
Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritisHaoling H Weng, Veena K Ranganath, Dinesh Khanna, et al.
The Journal of Rheumatology|August 3, 2011
Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working GroupRieke Alten, Christof Pohl, Ernest H Choy, et al.
The Journal of Rheumatology|December 7, 2005
Outcome measures for acute and chronic goutH Ralph Schumacher, Lawrence N Edwards, Fernando Perez-Ruiz, et al.
Arthritis and Rheumatism|May 30, 2006
Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosisRichard A Nash, Peter A McSweeney, J Lee Nelson, et al.
The Journal of Rheumatology|August 18, 2009
Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group)Clifton O Bingham, Christoph Pohl, Thasia G Woodworth, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 15, 2014
Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung diseaseElizabeth R Volkmann, Rajeev Saggar, Dinesh Khanna, et al.
ACR Open Rheumatology|December 5, 2020
Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and IIElizabeth R Volkmann, Virginia Steen, Ning Li, et al.
Disability and Rehabilitation|March 20, 2020
Identifying barriers and facilitators to physical activity for people with scleroderma: a nominal group technique studySami Harb, Julie Cumin, Danielle B Rice, et al.
Pageof 48